日本のオルソバイオロジクス市場レポート：製品タイプ、用途、エンドユーザー、地域別、2025～2033年

日本のオルソバイオロジクス市場規模は2024年に2億8,350万米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに5億820万米ドルに達し、2025～2033年の成長率（CAGR）は6.2％になると予測しています。座りがちなライフスタイルや肥満などのいくつかの要因から、変形性関節症や骨折などの整形外科疾患にかかりやすい高齢化人口の増加が、主に市場を牽引しています。

本レポートで扱う主要質問

• 日本のオルソバイオロジクス市場はこれまでどのように推移し、今後どのように推移していくのか？
• COVID-19が日本のオルソバイオロジクス市場に与えた影響は？
• 日本のオルソバイオロジクス市場の製品別区分は？
• 日本のオルソバイオロジクス市場のタイプ別区分は？
• 日本のオルソバイオロジクス市場の用途別区分は？
• 日本のオルソバイオロジクス市場のエンドユーザー別区分は？
• 日本のオルソバイオロジクス市場のバリューチェーンにおける様々なステージとは？
• 日本のオルソバイオロジクスの主要な促進要因と課題は何か？
• 日本のオルソバイオロジクス市場の構造と主要参入企業は？
• 日本のオルソバイオロジクス市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 オルソバイオロジクス市場-イントロダクション

• 概要
• 市場力学
• 産業動向
• 競合情報

第5章 オルソバイオロジクス市場情勢

• 過去と現在の市場動向（2019～2024年）
• 市場予測（2025～2033年）

第6章 オルソバイオロジクス市場-製品別内訳

• 脱灰骨基質
• 同種移植
• 骨形成タンパク質
• 関節内補充療法製品
• 合成骨代替物
• その他

第7章 オルソバイオロジクス市場-タイプ別内訳

• 膝
• 足首
• 腰
• 手首と肩
• 脊椎
• その他

第8章 オルソバイオロジクス市場-用途別内訳

• 変形性関節症と変性関節炎
• 脊椎固定術
• 骨折回復
• 軟部組織損傷
• 顎顔面と歯科用途

第9章 オルソバイオロジクス市場-エンドユーザー別内訳

• 病院と外来センター
• 研究・学術機関
• 歯科医院と施設
• 整形外科クリニック

第10章 オルソバイオロジクス市場-競合情勢

• 概要
• 市場構造
• 市場企業のポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第11章 主要企業のプロファイル

第12章 オルソバイオロジクス市場-産業分析

• 促進要因・抑制要因・機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第13章 付録

Japan orthobiologics market size reached USD 283.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 508.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.2% during 2025-2033. The growing aging population, who are prone to orthopedic conditions such as osteoarthritis and fracture, on account of several factors, like sedentary lifestyles and obesity, is primarily driving the market.

Orthobiologics is a field of medicine that focuses on using natural substances and biological materials to enhance the body's own healing processes, particularly in orthopedic and musculoskeletal conditions. These therapies aim to stimulate tissue repair and regeneration, reducing the need for more invasive surgical interventions and potentially improving patient outcomes. Common orthobiologics include platelet-rich plasma (PRP), which involves concentrating and injecting a patient's own platelets to promote tissue healing, and stem cell therapy, which utilizes a patient's own stem cells or those from a donor to encourage tissue regeneration. Additionally, there are products like bone grafts and synthetic materials that mimic the properties of natural bone to support fracture healing and spinal fusion. Orthobiologics represent a promising area of research and treatment in orthopedics, with the potential to accelerate recovery, reduce pain, and improve overall function in patients with various musculoskeletal conditions, such as arthritis, tendon injuries, and bone fractures.

Japan Orthobiologics Market Trends:

The orthobiologics market in Japan is experiencing robust growth, primarily driven by a confluence of factors that underscore its promising future. Firstly, an aging population has significantly contributed to the market's expansion. As individuals age, the incidence of musculoskeletal disorders such as osteoarthritis and fractures increases, necessitating orthobiologic treatments that facilitate tissue regeneration and repair. Consequently, the rising geriatric demographic acts as a substantial driving force for the market's growth. Furthermore, technological advancements have played a pivotal role in propelling the orthobiologics market forward. Innovations in biotechnology and regenerative medicine have led to the development of more sophisticated and effective orthobiologic products. This includes the emergence of stem cell therapies, platelet-rich plasma (PRP) treatments, and growth factor-based solutions, all of which offer improved patient outcomes, driving demand for these cutting-edge therapies. Additionally, the emerging application of minimally invasive procedures that offer quicker recovery times, reduced pain, and fewer complications is expected to drive the orthobiologics market in Japan during the forecast period.

Japan Orthobiologics Market Segmentation:

Product Insights:

• Demineralized Bone Matrix
• Allograft
• Bone Morphogenetic Protein
• Viscosupplementation Products
• Synthetic Bone Substitutes
• Others

Type Insights:

• Knee
• Ankle
• Hip
• Wrist and Shoulder
• Spine
• Others

Application Insights:

• Osteoarthritis and Degenerative Arthritis
• Spinal Fusion
• Fracture Recovery
• Soft Tissue Injuries
• Maxillofacial and Dental Applications

End User Insights:

• Hospitals and Ambulatory Centers
• Research and Academic Institutes
• Dental Clinics and Facilities
• Orthopedic Clinics

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan orthobiologics market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan orthobiologics market?
• What is the breakup of the Japan orthobiologics market on the basis of product?
• What is the breakup of the Japan orthobiologics market on the basis of type?
• What is the breakup of the Japan orthobiologics market on the basis of application?
• What is the breakup of the Japan orthobiologics market on the basis of end user?
• What are the various stages in the value chain of the Japan orthobiologics market?
• What are the key driving factors and challenges in the Japan orthobiologics?
• What is the structure of the Japan orthobiologics market and who are the key players?
• What is the degree of competition in the Japan orthobiologics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Orthobiologics Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Orthobiologics Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Orthobiologics Market - Breakup by Product

• 6.1 Demineralized Bone Matrix
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Allograft
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Bone Morphogenetic Protein
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Viscosupplementation Products
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)
• 6.5 Synthetic Bone Substitutes
  • 6.5.1 Overview
  • 6.5.2 Historical and Current Market Trends (2019-2024)
  • 6.5.3 Market Forecast (2025-2033)
• 6.6 Others
  • 6.6.1 Historical and Current Market Trends (2019-2024)
  • 6.6.2 Market Forecast (2025-2033)

7 Japan Orthobiologics Market - Breakup by Type

• 7.1 Knee
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Ankle
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Hip
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Wrist and Shoulder
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2019-2024)
  • 7.4.3 Market Forecast (2025-2033)
• 7.5 Spine
  • 7.5.1 Overview
  • 7.5.2 Historical and Current Market Trends (2019-2024)
  • 7.5.3 Market Forecast (2025-2033)
• 7.6 Others
  • 7.6.1 Historical and Current Market Trends (2019-2024)
  • 7.6.2 Market Forecast (2025-2033)

8 Japan Orthobiologics Market - Breakup by Application

• 8.1 Osteoarthritis and Degenerative Arthritis
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Spinal Fusion
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Fracture Recovery
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)
• 8.4 Soft Tissue Injuries
  • 8.4.1 Overview
  • 8.4.2 Historical and Current Market Trends (2019-2024)
  • 8.4.3 Market Forecast (2025-2033)
• 8.5 Maxillofacial and Dental Applications
  • 8.5.1 Overview
  • 8.5.2 Historical and Current Market Trends (2019-2024)
  • 8.5.3 Market Forecast (2025-2033)

9 Japan Orthobiologics Market - Breakup by End User

• 9.1 Hospitals and Ambulatory Centers
  • 9.1.1 Overview
  • 9.1.2 Historical and Current Market Trends (2019-2024)
  • 9.1.3 Market Forecast (2025-2033)
• 9.2 Research and Academic Institutes
  • 9.2.1 Overview
  • 9.2.2 Historical and Current Market Trends (2019-2024)
  • 9.2.3 Market Forecast (2025-2033)
• 9.3 Dental Clinics and Facilities
  • 9.3.1 Overview
  • 9.3.2 Historical and Current Market Trends (2019-2024)
  • 9.3.3 Market Forecast (2025-2033)
• 9.4 Orthopedic Clinics
  • 9.4.1 Overview
  • 9.4.2 Historical and Current Market Trends (2019-2024)
  • 9.4.3 Market Forecast (2025-2033)

10 Japan Orthobiologics Market - Competitive Landscape

• 10.1 Overview
• 10.2 Market Structure
• 10.3 Market Player Positioning
• 10.4 Top Winning Strategies
• 10.5 Competitive Dashboard
• 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

• 11.1 Company A
  • 11.1.1 Business Overview
  • 11.1.2 Product Portfolio
  • 11.1.3 Business Strategies
  • 11.1.4 SWOT Analysis
  • 11.1.5 Major News and Events
• 11.2 Company B
  • 11.2.1 Business Overview
  • 11.2.2 Product Portfolio
  • 11.2.3 Business Strategies
  • 11.2.4 SWOT Analysis
  • 11.2.5 Major News and Events
• 11.3 Company C
  • 11.3.1 Business Overview
  • 11.3.2 Product Portfolio
  • 11.3.3 Business Strategies
  • 11.3.4 SWOT Analysis
  • 11.3.5 Major News and Events
• 11.4 Company D
  • 11.4.1 Business Overview
  • 11.4.2 Product Portfolio
  • 11.4.3 Business Strategies
  • 11.4.4 SWOT Analysis
  • 11.4.5 Major News and Events
• 11.5 Company E
  • 11.5.1 Business Overview
  • 11.5.2 Product Portfolio
  • 11.5.3 Business Strategies
  • 11.5.4 SWOT Analysis
  • 11.5.5 Major News and Events

12 Japan Orthobiologics Market - Industry Analysis

• 12.1 Drivers, Restraints, and Opportunities
  • 12.1.1 Overview
  • 12.1.2 Drivers
  • 12.1.3 Restraints
  • 12.1.4 Opportunities
• 12.2 Porters Five Forces Analysis
  • 12.2.1 Overview
  • 12.2.2 Bargaining Power of Buyers
  • 12.2.3 Bargaining Power of Suppliers
  • 12.2.4 Degree of Competition
  • 12.2.5 Threat of New Entrants
  • 12.2.6 Threat of Substitutes
• 12.3 Value Chain Analysis

13 Appendix